Axa’s US IPO prices well below expectations

The sale of one of Axa’s US businesses, which will be used to fund the French insurance giant’s purchase of XL Group, is likely to bring in far less than it initially expected.


Want to read this article?


For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey

Commercial director

+44 (0) 7450 000929

    Andy Stone

    Sales manager

    +44 (0) 7834 843176